No Licence Renewal For Blood Centres Sans Hospital

Dehradun: All blood centres operating outside of hospitals in Uttarakhand will no longer be eligible for licence renewal, a circular issued on Saturday by the Uttarakhand Food and Drug Authority (FDA) said.

Currently, 82 blood centres are operational in the state, and this directive is expected to impact 30-35 of them, a source in the department said. However, centres run by organisations like Indian Medical Association (IMA) or those under Red Cross will not be affected, as they are classified as charity organisations, according to officials.

Existing centres with a five-year licence will not have to establish a hospital, but once the licences expire, they will not be renewed unless they have moved into hospital premises.

Tajber Singh, additional commissioner, state Food and Drug Administration, said, “Affiliation with any hospital won’t help. Blood centres must be within hospital premises, to ensure that patients in need of blood and plasma receive priority. It also promotes strict preservation of blood as per protocols.”

The move is expected to curb high prices charged by private blood banks during crises and to address issues of incorrect blood transfusions by promoting proper testing and storage of blood.

Related Posts

  • Pharma
  • July 16, 2025
  • 151 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 48 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients